免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy

NCT:NCT06411548 · COMPLETED

NCT IDNCT06411548
狀態COMPLETED
開始日期2025-03-27
完成時間2025-10-17
SponsorUniversity of Virginia (OTHER)
First posted
Last updated

簡要摘要

This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention. In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑